摘要
目的评价依达拉奉治疗蛛网膜下腔出血的疗效。方法 50例蛛网膜下腔出血患者,随机分为对照组和观察组。对照组给予尼莫地平;观察组在对照组用药方式的基础上,加用依达拉奉。结果观察组总有效率为88.00%高于对照组的64.00%,差异有统计学意义(P<0.05)。治疗后,观察组大脑中动脉血流速度低于对照组(P<0.05)。结论依达拉奉治疗蛛网膜下腔出血疗效可靠。
Objective To evaluate of the efficacy about edaravone treatment of subarachnoid hemorrhage. Methods All of 50 cases of subarachnoid hemorrhage were divided into the observation group and the control group. The control group： re- ceived nimodipine therapy. The observation group：edaravone sasuke nimodipine therapy. Results The total effective rate of the observation group was 88.00% was higher than the control group （64.00%）, （P 〈 0.05）. After treatment, the middle cere- bral artery blood flow velocity of the observation group was less than the control group with significant difference （P 〈 0.05）. Conclusion It＇s good efficacy that edaravone treatment of subarachnoid hemorrhage.
出处
《中国现代医生》
2012年第12期77-77,79,共2页
China Modern Doctor
